Jan 15, 2012 - 10:35 am
We have chatted about this off and on for a few years. That issue of the tissue assay is so baffling to me – so basic. Docs order scans and bloodwork, but assume that the standard drugs will always work. How many lives can be saved by being more exact in the selection of treatment. Have lives been shortened because vital information was not accessed?
Cynthia Rose's mother is an example of someone who did not have this test, received the standard treatment for upsc (carboplatin and taxol), and later learned that this treatment was not very effective as evidenced by rapid progression of tumors.
How many of us had doctor's that ordered this testing at beginning of treatment?
Since I did, I assumed that it was routine but sadly learned otherwise. It seems to me that this test can save time, money, and lives if done routinely. Am I off-base on this thinking? If not, is there anything we can do as a community of patients to help the community of doctor's (and insurance companies) see the importance in getting this test early on???
I am interested in your feedback and suggestions about this.